Electronic Resource
[s.l.]
:
Nature Publishing Group
Nature biotechnology
24 (2006), S. 729-729
ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] Exelixis just presented phase 1 clinical trial data for three new kinase inhibitors at the 2006 American Society of Clinical Oncology annual meeting held in Atlanta, Georgia June 2–3. The compounds are included in a licensing and development deal with GlaxoSmithKline (GSK) that gives the ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt0706-729
|
Location |
Call Number |
Expected |
Availability |